These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 924051)

  • 1. [Glycolipidemic variations during the double glucagon test in patients with liver diseases].
    Sgambato S; Carbone L; Torella R; Frascolla N; Drammis E
    G Clin Med; 1977; 58(7-8):301-11. PubMed ID: 924051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of glucagon on glucose and nonesterified fatty acids in chronic hepatic disease (author's transl)].
    Malinovská V; Holík K
    Cas Lek Cesk; 1974 Feb; 113(8):245-7. PubMed ID: 4434446
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of serum triglycerides, nonesterified fatty acids and phospholipids in acute and chronic hepatitis].
    Torjescu V; Ceauşu E; Văleanu M; Pîrvu D; Melencu M; Urcan M
    Med Interna (Bucur); 1968 Jul; 20(7):817-23. PubMed ID: 5685312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic significance of serum fatty acid determination in patients with chronic hepatitis and liver cirrhosis].
    Voloshchuk OA; Zvershkhanovskiĭ FA
    Vrach Delo; 1977 Aug; (8):77-80. PubMed ID: 919454
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on citrate metabolism in liver injuries. 1. Fasting blood citrate level in chronic hepatitis and liver cirrhosis.
    Kaneshige J
    Acta Med Okayama; 1975 Feb; 29(1):1-8. PubMed ID: 125999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free and esterified fatty acids in acute and chronic liver diseases].
    Martinelli M; Disertori M; Montero C
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1701-2. PubMed ID: 5524982
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver function test after nicotinic acid loading. I. A clinical study].
    Finck C; Jorke D
    Acta Hepatosplenol; 1968; 15(5):315-21. PubMed ID: 5707324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional diagnosis of chronic aggressive hepatitis and liver cirrhosis].
    Triandaf I; Mardare G; Pandele G; Triandaf N; Terek C; Ceangă L; Dobrescu G; Cotuţiu C; Duca M; Moroşanu V; Rugină V
    Rev Med Chir Soc Med Nat Iasi; 1981; 85(1):49-54. PubMed ID: 7280430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of various diagnostic parameters in chronic liver diseases].
    Heinicke HJ
    Z Gesamte Inn Med; 1973 Feb; 28(4):93-101. PubMed ID: 4540734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of the intravenous galactose tolerance test and serum vitamin B 12 level in the differential diagnosis and prognosis of liver diseases].
    Hugod C; Gade S; Krasilnikoff A; Kristensen HP
    Ugeskr Laeger; 1975 Jan; 137(3):141-5. PubMed ID: 1136025
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic value of serum bile acids in chronic diseases of the liver].
    Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
    Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of determining erythrocyte membrane permeability in the diagnosis of chronic liver diseases].
    Kolmakov VN; Radchenko VG
    Ter Arkh; 1982; 54(2):59-62. PubMed ID: 7071775
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic value of serum bile acid determination in chronic hepatitis and liver cirrhosis.
    Grigorescu M; Tăpălagă D; Dumitraşcu D; Suciu A
    Med Interne; 1980; 18(4):401-6. PubMed ID: 7455585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of liver function by means of the glucagon test].
    Brunner H; Grabner G; Michalek P; Paumgartner G
    Wien Z Inn Med; 1968; 49(11):409-17. PubMed ID: 5737590
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolic effect of administration of glucagon and a combination of glucagon and fructose to patients with cirrhosis of the liver and to healthy subjects (author's transl)].
    Brodanová M; Brodan V; Andĕl M; Kuhn E
    Sb Lek; 1976 Aug; 78(8):218-24. PubMed ID: 981947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatty acids in lipid fractions of blood serum in patients with chronic liver diseases].
    Markova MN; Loginov AS
    Ter Arkh; 1975; 47(2):84-92. PubMed ID: 1145465
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use of serum markers of fibrosis in chronic hepatitis.
    Trinchet JC
    J Hepatol; 1995; 22(2 Suppl):89-95. PubMed ID: 7665855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.